Cytosurge AG is a Swiss nanotechnology company providing innovative solutions based on the patented FluidFM technology. They are focusing their activities into three distinct customer-centric business units: AFM SOLUTIONS, CELL & BIOSCIENCE and 3DPRINTING, each perfectly adapted to its specific target market. They are committed to great customer experience, continuous innovation, and highest standards of quality made in Switzerland.

Contact Information

Overview

Total FundingEmployeesLast Funding DateStatus
11-50Operating